Tag: protection

WILMINGTON, Del., June 10, 2026 /PRNewswire/ -- Solenis, a leading global provider of water treatment, process and hygiene solutions, has entered into a strategic...

NEW YORK, June 10, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases,...

TAIPEI and LONDON, June 10, 2026 /PRNewswire/ -- KINGSTEEL recently visited D3O, a global leader in advanced protection materials, where the two companies officially...

TAIPEI and LONDON, June 10, 2026 /PRNewswire/ -- KINGSTEEL recently visited D3O, a global leader in advanced protection materials, where the two companies officially...

TAIPEI and LONDON, June 10, 2026 /PRNewswire/ -- KINGSTEEL recently visited D3O, a global leader in advanced protection materials, where the two companies officially...

TAIPEI and LONDON, June 10, 2026 /CNW/ -- KINGSTEEL recently visited D3O, a global leader in advanced protection materials, where the two companies officially...

TAIPEI and LONDON, June 10, 2026 /PRNewswire/ -- KINGSTEEL recently visited D3O, a global leader in advanced protection materials, where the two companies officially...

SINGAPORE, June 10, 2026 /PRNewswire/ -- Motul is proud to be the official lubricant partner of Great Wall Motor (GWM) Factory Racing for the...

A new cellulose-based material platform developed in Finland responds to tightening regulatory requirements and industry pressure to both replace and reduce plastic in packaging,...

NUREMBERG, Germany, June 10, 2026 /PRNewswire/ -- NOVOSENSE Microelectronics (SSE: 688052 | HKEX: 02676) is exhibiting at PCIM Europe 2026, held from June 9...

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

SHANGHAI, June 9, 2026 /PRNewswire/ -- Recently, Jinko ESS, a leading global energy storage company and a subsidiary of JinkoSolar Co., Ltd., completed the...